In summary, the present results demonstrate that stigmasterol have anti-inflammatory effects both locally and systemically, reduces the excessive production of Th 17 cells in the body, increases IL-10 levels and down-regulates IL-17A levels, to improve the symptoms of asthma in mice. Here, IL17A is linked to asthma.